NCT03675113

Brief Summary

Heart failure is a cardiac structural or functional disorder that, despite normal filling pressures, leads to inability to deliver enough oxygen to meet the metabolic needs o tissue. Heart failure is a serious chronic condition that affects a large proportion of the adult population in the world causing high mortality, leading to exercise intolerance and reduced health-related quality of life. Patients included in the cardiac rehabilitation program slow down disease progression, hospitalization decreases, quality of life improves and health expenditures decrease. Despite the frequent use of upper extremities in daily living activities, studies investigating the effect of upper extremity aerobic training on daily living activities, functional exercise capacity and other outcomes are limited. No studies have investigated the effect of upper extremity aerobic exercise training on physical activity level, functional and maximal exercise capacity and other measures in patients with heart failure.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Sep 2018

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 5, 2018

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

September 12, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 18, 2018

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2020

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2020

Completed
Last Updated

October 22, 2020

Status Verified

October 1, 2020

Enrollment Period

1.7 years

First QC Date

September 12, 2018

Last Update Submit

October 20, 2020

Conditions

Keywords

upper extremity aerobic exercisefunctional exercise capacitymaximal exercise capacityrespiratory endurancequality of lifedyspneapulmonary functionfatigueanxietydepression

Outcome Measures

Primary Outcomes (1)

  • Maximal exercise capacity

    It will be evaluated using symptom limited cardiopulmonary exercise testing. The cardiopulmonary exercise test will be performed at a progressively increasing speed and grade

    Second day

Secondary Outcomes (14)

  • Pulmonary function

    First day

  • Respiratory muscle strength

    First day

  • Pulmonary muscle endurance

    First day

  • Peripheral muscle strength

    First day

  • Grip strength

    First day

  • +9 more secondary outcomes

Study Arms (2)

upper extremity aerobic group

EXPERIMENTAL

The upper extremity aerobic exercise training with an arm ergometer will be performed in the treatment group so that training intensity will be between 60% and 80% of the maximum heart rate, dyspnea perception will be 3-4 according to Modified Borg Scale and fatigue perception will be 5-6 according to Modified Borg Scale, training duration will be 3 day per a week through 6-weeks.

Other: Upper extremity aerobic exercise

control group

SHAM COMPARATOR

Deep breathing exercises combination with arm movements will be given as a home program in the control group. Training duration will be 3 day per a week through 6-weeks.

Other: Control Group

Interventions

Range of maximal heart rate will be followed by a polar band during supervised session each week. Aerobic exercise will be trained for 30 min-per/day, 3 days/week, 6 weeks. All sessions are being performed by a physiotherapist at cardiopulmonary rehabilitation department.

upper extremity aerobic group

Deep breathing exercises combinated with arm movements

control group

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with a diagnosis of chronic heart failure diagnosed at rest below 40% of the left ventricular ejection fraction and class 1-3 according to the New York Heart Association classification
  • Optimal medical treatment at least 30 days and clinically stable

You may not qualify if:

  • Patients with unstable angina pectoris
  • Decompensated heart failure
  • Primary pulmonary hypertension
  • Complex ventricular arrhythmia
  • Contraindication to cardiopulmonary exercise testing
  • Patients who have had myocardial ischemia in the past 3 months
  • Ischemic cerebrovascular events
  • Second and third degree atrioventricular block
  • Thrombus detected in the left ventricle
  • Uncontrolled insulin dependent diabetes mellitus
  • Uncontrolled hypertension
  • Renal insufficiency
  • Acute infection
  • Aortic stenosis
  • Acute pulmonary embolism
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Gazi University

Ankara, Yenimahalle, 06500, Turkey (Türkiye)

Location

Gazi University Faculty of Health Science Department of Physiotherapy and Rehabilitation

Ankara, 06500, Turkey (Türkiye)

Location

Related Publications (3)

  • Giannuzzi P, Temporelli PL, Corra U, Tavazzi L; ELVD-CHF Study Group. Antiremodeling effect of long-term exercise training in patients with stable chronic heart failure: results of the Exercise in Left Ventricular Dysfunction and Chronic Heart Failure (ELVD-CHF) Trial. Circulation. 2003 Aug 5;108(5):554-9. doi: 10.1161/01.CIR.0000081780.38477.FA. Epub 2003 Jul 14.

    PMID: 12860904BACKGROUND
  • Ades PA, Keteyian SJ, Balady GJ, Houston-Miller N, Kitzman DW, Mancini DM, Rich MW. Cardiac rehabilitation exercise and self-care for chronic heart failure. JACC Heart Fail. 2013 Dec;1(6):540-7. doi: 10.1016/j.jchf.2013.09.002. Epub 2013 Oct 24.

    PMID: 24622007BACKGROUND
  • Antunes-Correa LM, Kanamura BY, Melo RC, Nobre TS, Ueno LM, Franco FG, Roveda F, Braga AM, Rondon MU, Brum PC, Barretto AC, Middlekauff HR, Negrao CE. Exercise training improves neurovascular control and functional capacity in heart failure patients regardless of age. Eur J Prev Cardiol. 2012 Aug;19(4):822-9. doi: 10.1177/1741826711414626. Epub 2011 Jun 22.

    PMID: 21697210BACKGROUND

MeSH Terms

Conditions

DyspneaFatigueAnxiety DisordersDepression

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsMental DisordersBehavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Hanım Eda GÖKTAŞ, MSc

    Gazi University

    STUDY CHAIR
  • Meral BOŞNAK GÜÇLÜ, PhD

    Gazi University

    STUDY DIRECTOR
  • Adnan ABACI, PhD

    Gazi University

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associate professor

Study Record Dates

First Submitted

September 12, 2018

First Posted

September 18, 2018

Study Start

September 5, 2018

Primary Completion

June 1, 2020

Study Completion

December 1, 2020

Last Updated

October 22, 2020

Record last verified: 2020-10

Data Sharing

IPD Sharing
Will not share

Locations